Research Progress of Lymph Node Micrometastasis in Non-small Cell Lung Cancer.
10.3779/j.issn.1009-3419.2018.07.08
- Author:
Yuhuan ZHAO
1
;
Donglai CHEN
2
;
Yongbing CHEN
1
Author Information
1. Department of Cardiothoracic Surgery, the Second Affiliated Hospital of Soochow University, Suzhou 215000, China.
2. Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
- Publication Type:Journal Article
- Keywords:
Lung neoplasms;
Lymph node;
Micrometastasis
- MeSH:
Biomarkers, Tumor;
metabolism;
Carcinoma, Non-Small-Cell Lung;
metabolism;
pathology;
Humans;
Lung Neoplasms;
metabolism;
pathology;
Neoplasm Micrometastasis;
Risk Factors
- From:
Chinese Journal of Lung Cancer
2018;21(7):547-552
- CountryChina
- Language:Chinese
-
Abstract:
The incidence and mortality of lung cancer rank top in China. One important factor is the occurrence of metastasis. With the development of science technology, the effect of surgical treatment on lung cancer is improved. Moreover, the use of targeted therapy has achieved a new height for the treatment of lung cancer. However, the recurrence rate remains high even the tumor was completely resected at early stage. The occurrence of lymph node micrometastasis is considered as one of the plausible explanations. The difficulty indetecting micrometastasis has been greatly reduced. Although studies dig deeper into the lymph node micrometastasis, there are still some controversies including the selection of surgical procedures, the pathological staging and prognosis about patients with lymph node micrometastasis. This review manages to generalize the latest research progress of lymph node micrometastasis.
.
